Evaluation of the Prognostic Value of Ki-67 in Early-Stage Breast Cancer

ASSESSMENT OF NEO-ADJUVANT THERAPY IN CORRELATION WITH THE PREDICTIVE ROLE OF KI67 INDEX IN CASES OF LOCALLY ADVANCED BREAST CANCER

Assessment of the Prognostic Role of Ki-67 and Its Optimal Cutoff Value in Early Breast Cancer: A Retrospective Analysis

CUTOFF VALUE OF KI-67 BIOMARKER AS PROGNOSTIC MARKER IN FEMALE BREAST CANCER

COX-2 “Cyclooxygenase 2“as a Prognostic marker in Breast Cancer

A RETROSPECTIVE ANALYSIS OF CLINICOPATHOLOGICAL DATA AND OUTCOMES OF HORMONAL POSITIVE HER2 NEGATIVE METASTATIC BREAST CANCER PATIENTS IN CLINICAL ONCOLOGY DEPARTMENT IN AIN SHAM

Ki 67 Expression in Molecular Sub types of Breast Cancer in Patients of Zagazig University Hospitals

Assessment of Response to Hormonal Therapy by Serum Ki-67 as a Biomarker in Non-metastatic Hormone Positive Breast Cancer: A Prospective Study

Role of Some Estrogen Receptor and Her2 Pathway related Genes (PIK3CA, GSK3 β) in Predicting Response to Tamoxifen in Breast Cancer Patients

Evaluation of the clinicopathological significance of E-Cadherin and Ki 67 immuno-expression in triple negative breast cancer